On-Time Screening based on Family History and Average Risk, Implications for Clinical Practice
The objectives of this talk:
Review available data on prevalence of on time screening for family history
Explore potential consequences of suboptimal rates of on time screening
Discuss potential messaging strategies to promote on-time screening for family history and average risk to inform patients and providers about demographic changes in CRC, and the critical issues of symptom recognition and early self-referral for evaluation
We’re requesting that questions be sent ahead of time (via the registration form) to help Dr. Jones and Dr. Gupta address certain topic areas.
Gastroenterologist, Professor of Medicine, UC San Diego Health
Samir Gupta, MD, is a board-certified gastroenterologist with expertise in general gastroenterology and in particular, colorectal cancer screening and prevention at UC San Diego Health. He has specific expertise in the evaluation and management of individuals with a family history of colorectal cancer, including individuals with family cancer syndromes such as Lynch syndrome and familial adenomatous polyposis. Dr. Gupta also has expertise in the evaluation and management of patients with complex polyps, such as large polyps (adenomas), sessile serrated adenomas, and the hyperplastic polyposis syndrome. His areas of clinical research include colorectal cancer screening and prevention. Specific work has included randomized controlled trials of strategies to increase screening rates for colorectal cancer, and observational studies seeking to identify novel methods for risk stratification of patients with polyps.
Whitney Jones, MD
Gastroenterologist, Colon Cancer Prevention Project
Dr. Whitney Jones is a practicing Gastroenterologist, former therapeutic endoscopist and Clinical Professor at the University of Louisville from 1994 until 2017. In 2003 he founded a 501C3, the Colon Cancer Prevention Project, a leading CRC information and advocacy organization focused on innovation and acceleration of evidence-based screening. Kentucky has since more than doubled its screening rates (now 71%) and reduced colon cancer deaths by a third. A major focus of the “Project” is advocacy through passing pragmatic state-based laws which lower barriers to access evidence based CRC screening. Currently, they include a funded state-based CRC screening program for the uninsured/underinsured, elimination the polyp loophole for screening colonoscopies and no cost sharing for colonoscopy to evaluate a positive FIT or sDNA test.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.